Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial
Author:
Reinhard G Bretzel,Ulrike Nuber,Wolfgang Landgraf,David R Owens,Clare Bradley,Thomas Linn
Date:
29 March–4 April 2008
Copyright © 2008 Elsevier Ltd. All rights reserved.